Delivery Order SPE2DB24D2212-SPE2DB25FHQLZ
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $17,796.50 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count packages) on July 21, 2025, with an ultimate completion date of July 22, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at...
- The Defense Logistics Agency awarded a delivery order valued at $68,762.13 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count) under a firm fixed price contract. The award, announced on September 23, 2025, with an ultimate completion date of September 24, 2025, represents a non-set-aside, competitively awarded procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $8,178.05 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count packages) under a firm fixed price contract. The award was made on July 30, 2025, with an ultimate completion date of July 31, 2025, and represents a non-set-aside competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a $19,435.63 delivery order to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count) on July 28, 2025, with an ultimate completion date of July 29, 2025. This firm fixed price contract was awarded competitively with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $22,131.79 to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Jardiance 10 mg tablets (90-count packages). This firm fixed-price, competitive award carries an ultimate completion date of August 21, 2025, and represents a child delivery order under AmerisourceBergen's broader contract vehicle with DLA. The contract is not set-aside and will be performed at the contractor's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $7,851.13 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count units) on July 29, 2025, with completion required by July 30, 2025. This firm fixed-price, non-set-aside contract was performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was selected through competitive procurement to...
- The Defense Logistics Agency awarded a delivery order valued at approximately $62K to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count units). The contract, which was competitively awarded without set-aside restrictions, carries a firm fixed price structure and a completion deadline of September 22, 2025. AmerisourceBergen will fulfill this order from its corporate office located in Conshohocken, Pennsylvania, where the company maintains its primary operations as a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,715.58 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets in a 90-count quantity. The contract was awarded on April 28, 2025, with an ultimate completion date of April 29, 2025, using firm fixed-price pricing with no set-aside designation. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract issued...
- The Defense Logistics Agency awarded a delivery order valued at $7,701.70 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count packages) on August 11, 2025, with an ultimate completion date of August 12, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The pharmaceutical will be supplied from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, and represents a small-value...
- The Defense Logistics Agency awarded a $11,502.77 delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Jardiance 10 mg tablets (90-count package), with a completion date of June 20, 2025. This contract was competitively awarded with no set-aside designation and operates under a firm fixed-price structure. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- SPE2DB24D2212Indefinite Delivery Contract
- SPE2DB24D2212-SPE2DB25FHQLZDelivery Order
The Defense Logistics Agency awarded a delivery order valued at approximately $28.7K to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count units) under a firm fixed-price contract. The award was made on August 6, 2025, with an ultimate completion date of August 7, 2025, with no set-aside designation applied. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled the order from its corporate office location at the same address. This delivery order represents a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.999 billion through December 2026. This prime IDC vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The Jardiance supply supports federal medical procurement needs for military and veteran healthcare systems, consistent with AmerisourceBergen Drug Corp's extensive portfolio of diabetes medications and other therapeutic products delivered through DLA's competitive acquisition processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $28.7k | 8/6/25 |